SER-155 Transplant Infection Data Enter Peer Reviewed Record

A Nature Medicine Phase 1b paper published online November 3 reports fewer bloodstream infections through day 100 after allogeneic hematopoietic cell transplantation with oral SER-155 than placebo in its randomized cohort. This peer-reviewed publication…




